Literature DB >> 7599140

The chemical modification of glycosaminoglycan structure by oxygen-derived species in vitro.

R Moseley1, R Waddington, P Evans, B Halliwell, G Embery.   

Abstract

The effect of reactive oxygen species (ROS) on the chemical structure of glycosaminoglycans (GAG) was studied in order to consider their role in connective tissue damage during an inflammatory disease state such as periodontal disease. GAG were exposed to a radical generating system for 1 h and analysed by gel filtration for fragmentation and chemically with respect to uronic acid, hexosamine and sulfate content. Non-sulfated GAG, hyaluronan and chondroitin, were most susceptible to depolymerisation and chemical modification of uronic acid and hexosamine residues by ROS. Depolymerisation and chemical modification of sulfated GAG, chondroitin 4-sulfate, dermatan sulfate and heparan sulfate was significantly less than for non-sulfated GAG. The highly sulfated GAG heparin showed minimal depolymerisation by ROS, but uronic acid residues were readily modified. Analysis of the ROS-exposed residues suggests that uronic acid is capable of degrading to a 3-carbon aldehyde, malondialdehyde. Chondroitin sulfate exposed to ROS resulted in marginal desulfation. The results suggest that the presence of sulfate on the GAG chain may protect the molecule against ROS attack. However, chemical modification of GAG may affect proteoglycan function and be of importance in considering connective tissue destruction in a variety of pathological situations, including periodontal disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7599140     DOI: 10.1016/0304-4165(95)00010-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

Review 1.  Oxidative depolymerization of polysaccharides by reactive oxygen/nitrogen species.

Authors:  Jinyou Duan; Dennis L Kasper
Journal:  Glycobiology       Date:  2010-10-28       Impact factor: 4.313

2.  Chitosan gallate as a novel potential polysaccharide antioxidant: an EPR study.

Authors:  Wanvimol Pasanphan; Garry R Buettner; Suwabun Chirachanchai
Journal:  Carbohydr Res       Date:  2009-10-02       Impact factor: 2.104

3.  Reactive oxygen species cause direct damage of Engelbreth-Holm-Swarm matrix.

Authors:  B Riedle; D Kerjaschki
Journal:  Am J Pathol       Date:  1997-07       Impact factor: 4.307

4.  Reactive oxygen species mediate high glucose-induced heparanase-1 production and heparan sulphate proteoglycan degradation in human and rat endothelial cells: a potential role in the pathogenesis of atherosclerosis.

Authors:  G Rao; H G Ding; W Huang; D Le; J B Maxhimer; A Oosterhof; T van Kuppevelt; H Lum; E J Lewis; V Reddy; R A Prinz; X Xu
Journal:  Diabetologia       Date:  2011-03-20       Impact factor: 10.122

Review 5.  Endothelial Glycocalyx and Cardiopulmonary Bypass.

Authors:  Gerard J Myers; Julie Wegner
Journal:  J Extra Corpor Technol       Date:  2017-09

6.  Oxidative stress in secondary osteoarthritis: from cartilage destruction to clinical presentation?

Authors:  Christoph Ziskoven; Marcus Jäger; Christoph Zilkens; Wilhelm Bloch; Klara Brixius; Rüdiger Krauspe
Journal:  Orthop Rev (Pavia)       Date:  2010-09-23

7.  Reactive oxygen species modulate the barrier function of the human glomerular endothelial glycocalyx.

Authors:  Anurag Singh; Raina D Ramnath; Rebecca R Foster; Emma C Wylie; Vincent Fridén; Ishita Dasgupta; Borje Haraldsson; Gavin I Welsh; Peter W Mathieson; Simon C Satchell
Journal:  PLoS One       Date:  2013-02-14       Impact factor: 3.240

8.  Oxygen-Dependent Changes in the N-Glycome of Murine Pulmonary Endothelial Cells.

Authors:  Akos Tiboldi; Johannes Führer; Wolfgang Schaubmayr; Eva Hunyadi-Gulyas; Marie Louise Zach; Beatrix Hochreiter; Andreas Spittler; Roman Ullrich; Klaus Markstaller; Friedrich Altmann; Klaus Ulrich Klein; Verena Tretter
Journal:  Antioxidants (Basel)       Date:  2021-12-04

Review 9.  The Endothelial Glycocalyx as a Double-Edged Sword in Microvascular Homeostasis and Pathogenesis.

Authors:  Nuria Villalba; Sheon Baby; Sarah Y Yuan
Journal:  Front Cell Dev Biol       Date:  2021-07-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.